CSL Behring AG
CSL Behring AG is a Biotech company based in Bern (Bern) recorded by Swissmedic as the authorisation holder for 21 human medicines. That places it 90 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Blutprodukte.
Key facts
| Sector | Biotech |
|---|---|
| City | Bern |
| Canton | Bern |
| Authorisation holder | Yes |
| Medicines | 21 |
| Founded | Not available |
| Employees | 1001-5000 |
| Parent group | CSL Limited |
| Activity | Not available |
| Website | cslbehring.ch |
Medicines authorised in Switzerland
CSL Behring AG is recorded by Swissmedic as the authorisation holder for 21 human medicines. The table shows 21 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
21 of 21 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Albumin CSL 5% | 52476 | B | B05AA01 | 1978-06-19 |
| Andembry 200 mg | 69158 | B | - | 2025-02-24 |
| Andembry 200 mg | 69553 | B | B06AC07 | 2025-02-24 |
| Berinert IV 500 | 51950 | B | B06AC01 | 1993-10-21 |
| Berinert SC 2000 IU | 67519 | B | B06AC01 | 2020-06-16 |
| Beriplex P/N 500 | 665 | B | B02BD01 | 2004-07-05 |
| Berirab 2 ml | 687 | B | J06BB05 | 2004-05-05 |
| Faktor X P Behring 600 I.E. | 47726 | B | B02BD04 | 1987-05-20 |
| Fibrogammin 250 I.E. | 671 | B | B02BD07 | 2003-10-13 |
| Haemate P 250 IE/600 IE Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 45780 | B | B02BD06 | 1984-06-19 |
| Haemocomplettan P 1 g | 50203 | B | B02BB01 | 1992-11-24 |
| Hemgenix 1x10 e13 gc/mL | 68780 | A | B02BD16 | 2023-12-07 |
| Hepatitis-B-Immunglobulin Behring | 674 | B | J06BB04 | 2004-03-01 |
| Hizentra | 61547 | B | J06BA01 | 2011-06-08 |
| Hizentra 200mg/ml | 66410 | B | - | 2017-06-22 |
| Kybernin P 500 | 46928 | B | B01AB02 | 1994-11-24 |
| Privigen | 58314 | B | J06BA02 | 2008-04-11 |
| Respreeza 50 mg/ml à 1 g | 65337 | B | B02AB02 | 2016-01-21 |
| Rhophylac 300 | 53609 | B | J06BB01 | 1996-03-08 |
| Tetagam P | 673 | B | J06BB02 | 2004-08-24 |
| Voncento 250/600 I.E. | 65477 | B | B02BD06 | 2015-08-11 |
Frequently asked questions
How many medicines does CSL Behring AG have authorised in Switzerland?
CSL Behring AG is recorded by Swissmedic as the authorisation holder for 21 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is CSL Behring AG based?
The Swiss location recorded for CSL Behring AG is Bern, Bern.
Is CSL Behring AG a Swissmedic authorisation holder?
Yes. CSL Behring AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.